Source: BBC Health News
No, it is not anticipated that home testing for breast cancer, ovarian cancer or prostate cancer will be available any time in the near future. However cervical cancer is unique due to it’s associated risk with the human papillomavirus (HPV or genital warts), 13 of it’s 100 variants apparently cause cancer.
The issue [...]
Source: U.S. Centers for Disease Control & Prevention
Rates of new diagnoses and rates of death from all cancers combined declined significantly in the most recent time period for men and women overall and for most racial and ethnic populations in the United States.
The drops are driven largely by declines in rates of new cases and [...]
You MAY have a medical malpractice case if:
_ You or a loved one were significantly injured from a surgical error or complication of surgery
_ You or a loved one were significantly injured from improper medical care or treatment
_ You or a loved one were diagnosed with breast, ovarian, prostate or other cancer after a year [...]
Source: British Medical Journal; Cancer Research UK
Companion studies to that previously mentioned here in this blog http://www.medicalmalpracticelawyerblogphiladelphia.com/?p=21 support the notion that Ovarian Cancer is problematic for clinicians and patients alike.
The British Medical Journal Study (Bristol) reviewed charts of over 200 women diagnosed with cancer finding that symptoms associated with Ovarian Cancer were reported by [...]
I admit that I am guilty of flaunting my former affiliation with the defense medical malpractice bar. I do so not to give me any particular credibility in discussing or advising on medical malpractice issue but because to not do so would invalidate the past 14 years of my life. Morever, even as a plaintiff [...]
Source: PLoS Medicine, July 28, 2009
Early detection of ovarian cancer (at less than 1 cm) continues to elude medical providers according to researchers. Currently, ovarian cancers are detected only in advanced stages resulting in high mortality (death rate) and a poor prognosis.
The majority of deaths to ovarian cancer are cause by serous tumors. [...]
An important and recently published study funded primarily by the National Cancer Institute suggest that current screening for ovarian cancer fails to detect the disease in its early stage.
Methodology under review was screening with transvaginal ultrasound (TVU) and serum biomarker CA 125. The majority of Ovarian Cancers identified were at late stage (III or IV). [...]